Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.

× No keyword cloud information.

5 in total

Review 1. Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.

Authors: Aikaterini Tsiogka; Johann W Bauer; Aikaterini Patsatsi
Journal: Acta Derm Venereol Date: 2021-01-20 Impact factor: 3.875

2. Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.

Authors: Coralie Zumelzu; Marina Alexandre; Christelle Le Roux; Patricia Weber; Alexis Guyot; Annie Levy; Françoise Aucouturier; Sabine Mignot-Grootenboer; Frédéric Caux; Eve Maubec; Catherine Prost-Squarcioni
Journal: Front Med (Lausanne) Date: 2018-09-27

3. Checkpoint inhibitor-associated cutaneous small vessel vasculitis.

Authors: Brianna Castillo; Julie Gibbs; Andrew S Brohl; Lucia Seminario-Vidal
Journal: JAAD Case Rep Date: 2018-08-11

Review 4. A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

Authors: Adriana T Lopez; Larisa Geskin
Journal: Oncologist Date: 2018-07-17

5. Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation.

Authors: Dennis Niebel; Dagmar Wilsmann-Theis; Thomas Bieber; Mark Berneburg; Joerg Wenzel; Christine Braegelmann
Journal: Dermatopathology (Basel) Date: 2022-03-18

5 in total